For Researchers

1. Research Grants for one to three years (up to $160,000 per annum for a maximum of three years). Research projects must be a medical research collaboration between researchers in Australia and Israel. These projects can be from any area of medical research. This includes research into medical devices, diagnostics and psychological research. AUSiMED also funds projects that focus on health promotion and disease prevention.
2. Clinical or Research Fellowships for either Australian or Israeli candidates (up to a maximum of $105,000 per fellowship per annum). Fellowships (of usually one year) are available to Australian and Israeli researchers participating in collaborative initiatives.
3. Short Stay Travel Grant to Israel (up to $3000 per visit). Reimbursement of up to $1500 for the cost of accommodation and food for a 3 or 4 day side trip to Israel, to meet potential collaborators. All flights are to be arranged at the Grantee’s cost (if the Grantee was already going to be in Europe, he or she would be able to arrange a side trip to Israel at little or no cost).
4. Joint PhD from two universities (up to $30,000 per annum for three years for studies leading to a PhD). Where a university in Australia has a formal written alliance with a university in Israel, it is possible for both universities to offer a joint PhD. AUSiMED is keen to support this type of PhD.
5. Post-doctoral Scholarships (up to $70,000 per annum). Post-doctoral scholarships (of varying lengths) will be available where research work will be carried out both in Australia and Israel. Therefore, this grant includes travel costs between countries.
6. Top Up Grants (up to $50,000). When submitting new grant applications to other funding bodies, AUSiMED could be mentioned as potentially offering additional “top up” funding for offshore work in Israel. Where the “top up” is required for an existing grant, AUSiMED will investigate whether the grant conditions for the approved project, will permit “topping up” to allow funds to be sent offshore.
7. Catalyst Grant (from $5,000 to $20,000). This funding is to purchase project critical external analytical or other services or expensive reagents required for a project with an Israeli collaborator, eg production of monoclonal antibodies, bioimaging, DNA sequencing, protein or peptide production or genetically modified animal models.

The AUSiMED Medical Science Review Board (MSRB) is responsible for reviewing and recommending applications. The MSRB consists of clinical, medical, scientific research and commercialisation specialists.

As part of the review process:
• Additional peer review may be requested by the Medical Science Review Board.
• Applicants might be asked to provide additional information in writing, or via teleconference.

Note regarding Conflict of Interest: Any member of the AUSiMED MSRB that has a conflict of interest with a particular application or research team will not be present during discussion of that application and will not participate in decision making regarding that application.

Selection Criteria for Research Projects
AUSiMED funds projects that meet the criteria described below – criteria must be met at a high level. This is not an exhaustive list, and should not be used for self-assessment of projects. It is indicative of the types of projects that AUSiMED considers appropriate to submit to donors.

1. The project must have a well-defined collaboration between Australian and Israeli researchers, with balanced input from both teams.
   This means that it should combine concepts, data and research expertise from both the Australian and Israeli research teams. Each team should identify a unique expertise from the other team that is needed to advance their collaborative research. For example, using a cohort of patients from one country to test the ideas from the other country would not be sufficient. It is necessary for each team to contribute intellectual input and capabilities to the direction of the project and analysis of results, such that neither team could do the project alone.
2. Key members of the research teams in Israel and Australia must have a track record of collaborating internationally, and delivering quality research outcomes.
3. We are seeking translational research focussing on clinical outcomes associated with prevention and/or treatment of disease.
4. Intellectual property from both teams must be identified and when combined, should provide an innovative solution to the medical problem being researched. Access to intellectual property owned by individuals and institutions must be verified before the project can commence.
5. Fundable projects must receive support from peer review of at least two experts in the field.
6. The funded project can be completed within two years.

Selection Criteria for Fellowships
Purpose: to advance the career of the Applicant so that on their return to Israel, they will be engaged in a more senior role that will benefit their Israeli organisation. Documented support from the Israeli organisation is required to confirm the benefits and expectations.

Selection of candidates is based on the following selection criteria:

1. Highly promising clinicians or Post-Doctoral researchers from an academic healthcare or medical research organisation in Israel, where that organisation and the sponsoring institution in Australia have provided strong written support for the proposed Fellowship.
2. Outstanding resume and proven track record of achievement in healthcare delivery, medical research or health education.
3. Confirmation that training and/or research in Australia will be for a period of one year. A second year may be added if funded from another source.
4. The scope of the Fellowship is to acquire skills or training and/or to carry out research that is available in Australia and not in Israel e.g. with leading researchers or clinicians in Australia with highly specialised skills and knowledge.
5. The skills and knowledge to be acquired by the Israeli Fellows will be filling a need that will greatly assist healthcare and/or medical research in Israel.